Royalty Pharma(RPRX) - 2025 Q2 - Quarterly Results

Exhibit 99.1 ROYALTY PHARMA REPORTS SECOND QUARTER 2025 RESULTS NEW YORK, NY, August 6, 2025 - Royalty Pharma plc (Nasdaq: RPRX) today reported financial results for the second quarter of 2025 and raised full year 2025 guidance for Portfolio Receipts. "We delivered excellent second quarter 2025 results, as the strength of our diversified portfolio drove 20% growth in Portfolio Receipts, and raised our full year guidance," said Pablo Legorreta, Royalty Pharma's founder and Chief Executive Officer. "Additiona ...